Evidence map›Paper›PMID 36978295›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Impact of Nucleic Acid Amplification Test on Clinical Outcomes in Patients with

Yota Yamada, Motoyasu Miyazaki, Hisako Kushima, Yukie Komiya, Akio Nakashima, Hiroshi Ishii, Osamu Imakyure

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Emerging Diagnostics inInternational journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yota YamadaDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Motoyasu MiyazakiDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.ORCID 0000-0002-4526-3045
Hisako KushimaDepartment of Infection Control and Prevention, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Yukie KomiyaDepartment of Infection Control and Prevention, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Akio NakashimaDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Hiroshi IshiiDepartment of Infection Control and Prevention, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.ORCID 0000-0002-2143-5922
Osamu ImakyureDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Fukuoka University · JP

Funding

Grant of The Clinical Research Promotion Foundation 220424
6 · The paper itself

Abstract

A nucleic acid amplification test (NAAT) is recommended to determine whether or not patients have a

Indexed as

clinical outcomeClostridioides difficilenucleic acid amplification test

Identifiers

PMID36978295
PMCPMC10044602
OpenAlexW4321500170

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read22
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.